Abbott Laboratories (ABT)
115.30
-1.50
(-1.28%)
USD |
NYSE |
Nov 07, 16:00
115.32
+0.02
(+0.02%)
After-Hours: 20:00
Abbott Laboratories Revenue (TTM): 41.22B for Sept. 30, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| September 30, 2024 | 41.22B |
| June 30, 2024 | 40.72B |
| March 31, 2024 | 40.33B |
| December 31, 2023 | 40.11B |
| September 30, 2023 | 39.96B |
| June 30, 2023 | 40.23B |
| March 31, 2023 | 41.50B |
| December 31, 2022 | 43.65B |
| September 30, 2022 | 45.03B |
| June 30, 2022 | 45.55B |
| March 31, 2022 | 44.51B |
| December 31, 2021 | 43.08B |
| September 30, 2021 | 42.31B |
| June 30, 2021 | 40.23B |
| March 31, 2021 | 37.34B |
| December 31, 2020 | 34.61B |
| September 30, 2020 | 32.22B |
| June 30, 2020 | 31.44B |
| March 31, 2020 | 32.10B |
| December 31, 2019 | 31.90B |
| September 30, 2019 | 31.36B |
| June 30, 2019 | 30.94B |
| March 31, 2019 | 30.72B |
| December 31, 2018 | 30.58B |
| September 30, 2018 | 30.40B |
| Date | Value |
|---|---|
| June 30, 2018 | 29.58B |
| March 31, 2018 | 28.44B |
| December 31, 2017 | 27.39B |
| September 30, 2017 | 25.13B |
| June 30, 2017 | 23.61B |
| March 31, 2017 | 22.30B |
| December 31, 2016 | 20.85B |
| September 30, 2016 | 20.71B |
| June 30, 2016 | 20.56B |
| March 31, 2016 | 20.39B |
| December 31, 2015 | 20.40B |
| September 30, 2015 | 20.57B |
| June 30, 2015 | 20.50B |
| March 31, 2015 | 20.39B |
| December 31, 2014 | 20.25B |
| September 30, 2014 | 19.90B |
| June 30, 2014 | 19.65B |
| March 31, 2014 | 20.04B |
| December 31, 2013 | 20.66B |
| September 30, 2013 | 18.84B |
| June 30, 2013 | 19.28B |
| March 31, 2013 | 19.14B |
| December 31, 2012 | 19.05B |
| September 30, 2012 | 8.795B |
| June 30, 2012 | 13.35B |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
31.44B
Minimum
Jun 2020
45.55B
Maximum
Jun 2022
39.40B
Average
40.28B
Median
Revenue (TTM) Benchmarks
| Boston Scientific Corp | 15.91B |
| Becton Dickinson & Co | 19.83B |
| ResMed Inc | 4.807B |
| Integra Lifesciences Holdings Corp | 1.565B |
| QuidelOrtho Corp | 2.835B |